Radiation dose escalation in locally advanced oesophageal cancer: a systematic review and hierarchical Bayesian meta-analysisResearch in context
Summary: Background: The impact of radiation dose escalation in locally advanced oesophageal cancer remains controversial. While higher doses may improve locoregional control, their effect on overall survival (OS) and progression-free survival (PFS) remains uncertain. The aim of this study was to t...
Saved in:
| Main Authors: | , , , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2025-09-01
|
| Series: | EClinicalMedicine |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2589537025003645 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849399153198628864 |
|---|---|
| author | Yang-Hong Dai Po-Huang Chen Yi-Jhih Huang Ding-Jie Lee Po-Chien Shen Cheng-Hsiang Lo Yu-Guang Chen Yu-Fu Su Jen-Fu Yang Ying-Fu Wang Wen-Yen Huang Chun-Shu Lin Chih-Cheng Tsao Katherine A. Vallis |
| author_facet | Yang-Hong Dai Po-Huang Chen Yi-Jhih Huang Ding-Jie Lee Po-Chien Shen Cheng-Hsiang Lo Yu-Guang Chen Yu-Fu Su Jen-Fu Yang Ying-Fu Wang Wen-Yen Huang Chun-Shu Lin Chih-Cheng Tsao Katherine A. Vallis |
| author_sort | Yang-Hong Dai |
| collection | DOAJ |
| description | Summary: Background: The impact of radiation dose escalation in locally advanced oesophageal cancer remains controversial. While higher doses may improve locoregional control, their effect on overall survival (OS) and progression-free survival (PFS) remains uncertain. The aim of this study was to thoroughly evaluate the impact of dose escalation on survival. Methods: A systematic search on Jan 4, 2025, identified studies evaluating definitive chemoradiotherapy (CRTx) for locally advanced oesophageal cancer stratified by radiation dose. Bayesian and frequentist meta-analyses assessed OS, PFS, and locoregional PFS (LRPFS). Meta-regression examined the influence of histology, tumour location, chemotherapy, and radiation techniques. Additional analyses included gene set enrichment analysis and immune infiltration estimation. This study is registered with PROSPERO, CRD42024538961. Findings: A total of 42 studies involving 8379 patients were included. High-dose radiotherapy significantly improved LRPFS, with the largest benefit observed at 1-year (median difference: 18.6%; 95% credible interval [CrI]: 10.7–26.1%). A modest improvement in OS was noted at 3-year (7.0%; 95% CrI: 0.01–13.9%), particularly in squamous cell carcinoma (SqCC). Meta-regression identified SqCC and taxane-based chemotherapy as key moderators, with high-dose conferring greater benefits in Asian populations. Genomic analysis revealed higher radiosensitivity and significant immune activation in Asian SqCC. Taxane-based chemotherapy regimens were the strongest predictors of 1-/2-year OS and PFS but diminished at 5-year. Any-grade pneumonitis was more common in high-dose, but frequencies of grade 3 or higher pneumonitis were similar. Modern techniques like intensity-modulated or volumetric-modulated radiotherapy were associated with higher complete response rate and a trend toward reduced toxicity. The study heterogeneity was moderate to high across pooled estimates but addressed through hierarchical modeling and subgroup/sensitivity analyses. Most included studies were retrospective with moderate risk of bias, and the certainty of evidence for primary outcomes was rated as low to high. Interpretation: Radiation dose escalation improves locoregional control and may enhance OS in SqCC, particularly in Asian populations, highlighting the need for histology- and region-specific therapeutic strategies. The choice of chemotherapy regimen may affect the interpretation of survival effects associated with high-dose. Furthermore, the genomic correlates of radiosensitivity and immune activation suggest potential for biologically guided dose personalization and combination with immunotherapy. Funding: None. |
| format | Article |
| id | doaj-art-8576dc09e4174e20b72164bcd7ff9720 |
| institution | Kabale University |
| issn | 2589-5370 |
| language | English |
| publishDate | 2025-09-01 |
| publisher | Elsevier |
| record_format | Article |
| series | EClinicalMedicine |
| spelling | doaj-art-8576dc09e4174e20b72164bcd7ff97202025-08-20T03:38:24ZengElsevierEClinicalMedicine2589-53702025-09-018710343210.1016/j.eclinm.2025.103432Radiation dose escalation in locally advanced oesophageal cancer: a systematic review and hierarchical Bayesian meta-analysisResearch in contextYang-Hong Dai0Po-Huang Chen1Yi-Jhih Huang2Ding-Jie Lee3Po-Chien Shen4Cheng-Hsiang Lo5Yu-Guang Chen6Yu-Fu Su7Jen-Fu Yang8Ying-Fu Wang9Wen-Yen Huang10Chun-Shu Lin11Chih-Cheng Tsao12Katherine A. Vallis13Department of Oncology, University of Oxford, Oxford, UK; Department of Radiation Oncology, Tri-Service General Hospital, National Defense Medical University, Taipei, TaiwanDivision of Haematology and Oncology, Department of Internal Medicine, Tri-Service General Hospital, National Defense Medical University, Taipei, TaiwanDepartment of Oncology, University of Oxford, Oxford, UK; Division of Thoracic Surgery, Department of Surgery, Tri-Service General Hospital, National Defense Medical University, Taipei, TaiwanDivision of Nephrology, Department of Internal Medicine, Tri-Service General Hospital Keelung Branch, National Defense Medical University, Taiwan; Department of Biological Science and Technology, Institute of Bioinformatics and System Biology, National Yang Ming Chiao Tung University, Hsinchu, TaiwanDepartment of Radiation Oncology, Tri-Service General Hospital, National Defense Medical University, Taipei, TaiwanDepartment of Radiation Oncology, Tri-Service General Hospital, National Defense Medical University, Taipei, TaiwanDivision of Haematology and Oncology, Department of Internal Medicine, Tri-Service General Hospital, National Defense Medical University, Taipei, TaiwanDepartment of Radiation Oncology, Tri-Service General Hospital, National Defense Medical University, Taipei, TaiwanDepartment of Radiation Oncology, Tri-Service General Hospital, National Defense Medical University, Taipei, TaiwanDepartment of Radiation Oncology, Tri-Service General Hospital, National Defense Medical University, Taipei, TaiwanDepartment of Radiation Oncology, Tri-Service General Hospital, National Defense Medical University, Taipei, TaiwanDepartment of Radiation Oncology, Tri-Service General Hospital, National Defense Medical University, Taipei, TaiwanDepartment of Radiation Oncology, Taitung MacKay Memorial Hospital, Taitung, Taiwan; Corresponding author.Department of Oncology, University of Oxford, Oxford, UK; Corresponding author. Department of Oncology, University of Oxford, Oxford OX3 7DQ, UK.Summary: Background: The impact of radiation dose escalation in locally advanced oesophageal cancer remains controversial. While higher doses may improve locoregional control, their effect on overall survival (OS) and progression-free survival (PFS) remains uncertain. The aim of this study was to thoroughly evaluate the impact of dose escalation on survival. Methods: A systematic search on Jan 4, 2025, identified studies evaluating definitive chemoradiotherapy (CRTx) for locally advanced oesophageal cancer stratified by radiation dose. Bayesian and frequentist meta-analyses assessed OS, PFS, and locoregional PFS (LRPFS). Meta-regression examined the influence of histology, tumour location, chemotherapy, and radiation techniques. Additional analyses included gene set enrichment analysis and immune infiltration estimation. This study is registered with PROSPERO, CRD42024538961. Findings: A total of 42 studies involving 8379 patients were included. High-dose radiotherapy significantly improved LRPFS, with the largest benefit observed at 1-year (median difference: 18.6%; 95% credible interval [CrI]: 10.7–26.1%). A modest improvement in OS was noted at 3-year (7.0%; 95% CrI: 0.01–13.9%), particularly in squamous cell carcinoma (SqCC). Meta-regression identified SqCC and taxane-based chemotherapy as key moderators, with high-dose conferring greater benefits in Asian populations. Genomic analysis revealed higher radiosensitivity and significant immune activation in Asian SqCC. Taxane-based chemotherapy regimens were the strongest predictors of 1-/2-year OS and PFS but diminished at 5-year. Any-grade pneumonitis was more common in high-dose, but frequencies of grade 3 or higher pneumonitis were similar. Modern techniques like intensity-modulated or volumetric-modulated radiotherapy were associated with higher complete response rate and a trend toward reduced toxicity. The study heterogeneity was moderate to high across pooled estimates but addressed through hierarchical modeling and subgroup/sensitivity analyses. Most included studies were retrospective with moderate risk of bias, and the certainty of evidence for primary outcomes was rated as low to high. Interpretation: Radiation dose escalation improves locoregional control and may enhance OS in SqCC, particularly in Asian populations, highlighting the need for histology- and region-specific therapeutic strategies. The choice of chemotherapy regimen may affect the interpretation of survival effects associated with high-dose. Furthermore, the genomic correlates of radiosensitivity and immune activation suggest potential for biologically guided dose personalization and combination with immunotherapy. Funding: None.http://www.sciencedirect.com/science/article/pii/S2589537025003645Oesophageal cancerRadiation therapyDose escalationBayesian meta-analysisChemoradiotherapySurvival outcomes |
| spellingShingle | Yang-Hong Dai Po-Huang Chen Yi-Jhih Huang Ding-Jie Lee Po-Chien Shen Cheng-Hsiang Lo Yu-Guang Chen Yu-Fu Su Jen-Fu Yang Ying-Fu Wang Wen-Yen Huang Chun-Shu Lin Chih-Cheng Tsao Katherine A. Vallis Radiation dose escalation in locally advanced oesophageal cancer: a systematic review and hierarchical Bayesian meta-analysisResearch in context EClinicalMedicine Oesophageal cancer Radiation therapy Dose escalation Bayesian meta-analysis Chemoradiotherapy Survival outcomes |
| title | Radiation dose escalation in locally advanced oesophageal cancer: a systematic review and hierarchical Bayesian meta-analysisResearch in context |
| title_full | Radiation dose escalation in locally advanced oesophageal cancer: a systematic review and hierarchical Bayesian meta-analysisResearch in context |
| title_fullStr | Radiation dose escalation in locally advanced oesophageal cancer: a systematic review and hierarchical Bayesian meta-analysisResearch in context |
| title_full_unstemmed | Radiation dose escalation in locally advanced oesophageal cancer: a systematic review and hierarchical Bayesian meta-analysisResearch in context |
| title_short | Radiation dose escalation in locally advanced oesophageal cancer: a systematic review and hierarchical Bayesian meta-analysisResearch in context |
| title_sort | radiation dose escalation in locally advanced oesophageal cancer a systematic review and hierarchical bayesian meta analysisresearch in context |
| topic | Oesophageal cancer Radiation therapy Dose escalation Bayesian meta-analysis Chemoradiotherapy Survival outcomes |
| url | http://www.sciencedirect.com/science/article/pii/S2589537025003645 |
| work_keys_str_mv | AT yanghongdai radiationdoseescalationinlocallyadvancedoesophagealcancerasystematicreviewandhierarchicalbayesianmetaanalysisresearchincontext AT pohuangchen radiationdoseescalationinlocallyadvancedoesophagealcancerasystematicreviewandhierarchicalbayesianmetaanalysisresearchincontext AT yijhihhuang radiationdoseescalationinlocallyadvancedoesophagealcancerasystematicreviewandhierarchicalbayesianmetaanalysisresearchincontext AT dingjielee radiationdoseescalationinlocallyadvancedoesophagealcancerasystematicreviewandhierarchicalbayesianmetaanalysisresearchincontext AT pochienshen radiationdoseescalationinlocallyadvancedoesophagealcancerasystematicreviewandhierarchicalbayesianmetaanalysisresearchincontext AT chenghsianglo radiationdoseescalationinlocallyadvancedoesophagealcancerasystematicreviewandhierarchicalbayesianmetaanalysisresearchincontext AT yuguangchen radiationdoseescalationinlocallyadvancedoesophagealcancerasystematicreviewandhierarchicalbayesianmetaanalysisresearchincontext AT yufusu radiationdoseescalationinlocallyadvancedoesophagealcancerasystematicreviewandhierarchicalbayesianmetaanalysisresearchincontext AT jenfuyang radiationdoseescalationinlocallyadvancedoesophagealcancerasystematicreviewandhierarchicalbayesianmetaanalysisresearchincontext AT yingfuwang radiationdoseescalationinlocallyadvancedoesophagealcancerasystematicreviewandhierarchicalbayesianmetaanalysisresearchincontext AT wenyenhuang radiationdoseescalationinlocallyadvancedoesophagealcancerasystematicreviewandhierarchicalbayesianmetaanalysisresearchincontext AT chunshulin radiationdoseescalationinlocallyadvancedoesophagealcancerasystematicreviewandhierarchicalbayesianmetaanalysisresearchincontext AT chihchengtsao radiationdoseescalationinlocallyadvancedoesophagealcancerasystematicreviewandhierarchicalbayesianmetaanalysisresearchincontext AT katherineavallis radiationdoseescalationinlocallyadvancedoesophagealcancerasystematicreviewandhierarchicalbayesianmetaanalysisresearchincontext |